Tavapadon
Modify Date: 2024-01-02 07:22:51
Tavapadon structure
|
Common Name | Tavapadon | ||
|---|---|---|---|---|
| CAS Number | 1643489-24-0 | Molecular Weight | 391.344 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C19H16F3N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TavapadonTavapadon (PF 6649751, PF-06649751) is an orally available dopamine D1 receptor partial agonist for treatment of Parkinson's disease. Parkinson Disease Discontinued |
| Name | Tavapadon |
|---|---|
| Synonym | More Synonyms |
| Description | Tavapadon (PF 6649751, PF-06649751) is an orally available dopamine D1 receptor partial agonist for treatment of Parkinson's disease. Parkinson Disease Discontinued |
|---|---|
| References | References 1. PCT Int. Appl. (2014), WO 2014207601 A1 20141231. View Related Products by Target Dopamine Receptor Parkinson Disease |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C19H16F3N3O3 |
| Molecular Weight | 391.344 |
| Exact Mass | 391.114380 |
| LogP | 3.66 |
| Index of Refraction | 1.549 |
| 1,5-Dimethyl-6-(2-methyl-4-{[3-(trifluoromethyl)-2-pyridinyl]oxy}phenyl)-2,4(1H,3H)-pyrimidinedione |
| Tavapadon |
| 2,4(1H,3H)-Pyrimidinedione, 1,5-dimethyl-6-[2-methyl-4-[[3-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]- |